Multiple Myeloma Minimum Residual Disease by Flow Cytometry

3002069
copy
 

Copy Utility


emailprint
Example Reports
Negative
Positive

Icon

Time Sensitive

Icon

Additional Technical Information

Ordering Recommendation

Limited phenotyping panel to enumerate and characterize plasma cells in patient with previously established diagnosis of plasma cell dyscrasia. If no prior flow immunophenotyping has been performed, order Leukemia/Lymphoma Phenotyping Evaluation by Flow Cytometry (3001780).

Mnemonic

MM MRD

Methodology

Flow Cytometry

Performed

Sun-Sat

Reported

1-2 days

New York DOH Approval Status

Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.

Specimen Required

Patient Preparation
Collect

Bone marrow in Green (Sodium Heparin)

Specimen Preparation

Transport 5 mL bone marrow. (Min: 1 mL) Do not freeze.

Storage/Transport Temperature

Room temperature. Also acceptable: Refrigerated. Specimen should be received within 24 hours of collection for optimal cell viability.

Unacceptable Conditions
Remarks
Stability

Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable

Reference Interval

Interpretive Data

Refer to report.

Compliance Category

Analyte Specific Reagent (ASR)

Note

Hotline History

N/A

CPT Codes

88184; 88185 x9; 88188

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3002083 MM MRD Interpretation 48767-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Multiple Myeloma
  • Plasma Cell Dyscrasia
  • Plasma Cell MRD
Multiple Myeloma Minimum Residual Disease by Flow Cytometry